However, several types of cancer have developed a broad spectrum of immune escape mechanisms that down-modulate the NKG2D-mediated immune surveillance by metalloproteinases-driven proteolytic shedding and release of soluble NKG2DLs (16–20). This evidence concerns the gene KLRK1 and cancer.